You're offline — showing cached data
BibaMoney TVIJO AIOS NETWORK

Johnson & Johnson

JNJ · NYSE
Healthcare · Drug Manufacturers - General
$263.81 -1.42% today
—Market cap
—P/E (TTM)
—Net margin
—Revenue / share

About Johnson & Johnson

Johnson & Johnson is a healthcare holding company that researches, develops, manufactures, and sells products across the healthcare field. It operates through two segments: Innovative Medicine, which focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension, and MedTech, which includes products for interventional solutions, orthopaedics, surgery, and vision. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr.

Why it matters

Johnson & Johnson is one of the largest healthcare companies in the world by revenue and market capitalization, with a diversified portfolio spanning pharmaceuticals and medical devices. Its scale, broad product range, and long operating history make it a widely followed constituent of major market indices and a bellwether for the healthcare sector. Investors and traders monitor the company's segment performance, product pipeline, and litigation developments as part of assessing the broader drug manufacturing and medical technology landscape.

Company site ↗

How we research JNJ

Fundamentals like the ones above feed our fundamental screen — EPS acceleration, ROE and momentum∧quality — the one research class that survives walk-forward in our testing. We don’t issue price targets or buy/sell calls: see /edge for how rigorously (and how rarely) anything passes. This page is market data and research, not investment advice.

Data updated 18:00 UTC, 26 Oct 2026 · source: Financial Modeling Prep via Tvijo AIOS.